171 related articles for article (PubMed ID: 11196691)
1. Targeting the mucosa: genetically engineered vaccines and mucosal immune responses.
Stevceva L; Abimiku AG; Franchini G
Genes Immun; 2000 Jun; 1(5):308-15. PubMed ID: 11196691
[TBL] [Abstract][Full Text] [Related]
2. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
[TBL] [Abstract][Full Text] [Related]
3. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
4. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
[TBL] [Abstract][Full Text] [Related]
5. Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses.
Huang X; Liu L; Ren L; Qiu C; Wan Y; Xu J
Vaccine; 2007 Dec; 25(52):8874-84. PubMed ID: 18061316
[TBL] [Abstract][Full Text] [Related]
6. Novel strategies using DNA for the induction of mucosal immunity.
McCluskie MJ; Davis HL
Crit Rev Immunol; 1999; 19(4):303-29. PubMed ID: 10530431
[TBL] [Abstract][Full Text] [Related]
7. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
Kent SJ; Dale CJ; Ranasinghe C; Stratov I; De Rose R; Chea S; Montefiori DC; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Law M; Wilson KM; Ramsay AJ
Vaccine; 2005 Oct; 23(42):5009-21. PubMed ID: 15985317
[TBL] [Abstract][Full Text] [Related]
8. Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex.
Garzón MR; Berraondo P; Crettaz J; Ochoa L; Vera M; Lasarte JJ; Vales A; Van Rooijen N; Ruiz J; Prieto J; Zulueta J; González-Aseguinolaza G
Vaccine; 2005 Feb; 23(11):1384-92. PubMed ID: 15661387
[TBL] [Abstract][Full Text] [Related]
9. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
10. Mucosal immune responses associated with polynucleotide vaccination.
Malone JG; Bergland PJ; Liljestrom P; Rhodes GH; Malone RW
Behring Inst Mitt; 1997 Feb; (98):63-72. PubMed ID: 9382771
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.
Wang X; Zhang X; Kang Y; Jin H; Du X; Zhao G; Yu Y; Li J; Su B; Huang C; Wang B
Vaccine; 2008 Sep; 26(40):5135-44. PubMed ID: 18462848
[TBL] [Abstract][Full Text] [Related]
12. Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria.
Cortes-Perez NG; Lefèvre F; Corthier G; Adel-Patient K; Langella P; Bermúdez-Humarán LG
Vaccine; 2007 Sep; 25(36):6581-8. PubMed ID: 17675182
[TBL] [Abstract][Full Text] [Related]
13. Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice.
Guo L; Wang J; Zhou H; Si H; Wang M; Song J; Han B; Shu Y; Ren L; Qu J; Hung T
Vaccine; 2008 Jan; 26(4):460-8. PubMed ID: 18160189
[TBL] [Abstract][Full Text] [Related]
14. Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera.
Xu G; Wang S; Zhuang L; Hackett A; Gu L; Zhang L; Zhang C; Wang H; Huang Z; Lu S
Vaccine; 2009 Jun; 27(29):3821-30. PubMed ID: 19443090
[TBL] [Abstract][Full Text] [Related]
15. Mucosal and systemic immunization with targeted fusion anti-caries DNA plasmid in young rats.
Liu GX; Xu QA; Jin J; Li YH; Jia R; Guo JH; Fan MW
Vaccine; 2009 May; 27(22):2940-7. PubMed ID: 19428904
[TBL] [Abstract][Full Text] [Related]
16. Recent developments in mucosal delivery of pDNA vaccines.
Barnes AG; Barnfield C; Brew R; Klavinskis LS
Curr Opin Mol Ther; 2000 Feb; 2(1):87-93. PubMed ID: 11249656
[TBL] [Abstract][Full Text] [Related]
17. Mucosal application of plasmid-encoded IL-15 sustains a highly protective anti-Herpes simplex virus immunity.
Toka FN; Rouse BT
J Leukoc Biol; 2005 Jul; 78(1):178-86. PubMed ID: 15817700
[TBL] [Abstract][Full Text] [Related]
18. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA
Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
[TBL] [Abstract][Full Text] [Related]
19. Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII.
Ramanathan MP; Kutzler MA; Kuo YC; Yan J; Liu H; Shah V; Bawa A; Selling B; Sardesai NY; Kim JJ; Weiner DB
Vaccine; 2009 Jul; 27(32):4370-80. PubMed ID: 19497647
[TBL] [Abstract][Full Text] [Related]
20. Protective immunity induced by systemic and mucosal delivery of DNA vaccine expressing glycoprotein B of pseudorabies virus.
Yoon HA; Han YW; Aleyas AG; George JA; Kim SJ; Kim HK; Song HJ; Cho JG; Eo SK
J Microbiol Biotechnol; 2008 Mar; 18(3):591-9. PubMed ID: 18388482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
